Page 101 - AIH-1-2
P. 101
Artificial Intelligence in Health Combating XDR-bacteria as we approach 2050
52. Fields FR, Lee SW, McConnell MJ. Using bacterial genomes doi: 10.2174/1872210513666190308133429
and essential genes for the development of new antibiotics. 57. Tarín-Pelló A, Suay-García B, Pérez-Gracia MT. Antibiotic
Biochem Pharmacol. 2017;134:74-86.
resistant bacteria: Current situation and treatment options
doi: 10.1016/j.bcp.2016.12.002 to accelerate the development of a new antimicrobial
arsenal. Expert Rev Anti Infect Ther. 2022;20(8):1095-1108.
53. Rana R, Awasthi R, Sharma B, Kulkarni GT. Nanoantibiotic
formulations to combat antibiotic resistance - old doi: 10.1080/14787210.2022.2078308
wine in a new bottle. Recent Pat Drug Deliv Formul. 58. Lv S, Wang Y, Jiang K, et al. Genetic engineering and
2019;13(3):174-183.
biosynthesis technology: Keys to unlocking the chains of
doi: 10.2174/1872211313666190911124626 phage therapy. Viruses. 2023;15(8):1736.
54. Munir MU, Ahmed A, Usman M, Salman S. Recent advances doi: 10.3390/v15081736
in nanotechnology-aided materials in combating microbial
resistance and functioning as antibiotics substitutes. Int J 59. Zeituni EM, Raterman EL. NIAID’s comprehensive support
Nanomedicine. 2020;15:7329-7358. mechanisms for antibiotic development. ACS Infect Dis.
2020;6(6):1299-1301.
doi: 10.2147/IJN.S265934
doi: 10.1021/acsinfecdis.0c00099
55. Manrique PD, López CA, Gnanakaran S, Rybenkov VV,
Zgurskaya HI. New understanding of multidrug efflux 60. Lluka T, Stokes JM. Antibiotic discovery in the artificial
and permeation in antibiotic resistance, persistence, and intelligence era. Ann N Y Acad Sci. 2023;1519(1):74-93.
heteroresistance. Ann N Y Acad Sci. 2023;1519(1):46-62. doi: 10.1111/nyas.14930
doi: 10.1111/nyas.14921 61. Xavier BB, Das AJ, Cochrane G, et al. Consolidating and
exploring antibiotic resistance gene data resources. J Clin
56. Mulat M, Pandita A, Khan F. Medicinal plant compounds
for combating the multi-drug resistant pathogenic bacteria: Microbiol. 2016;54(4):851-859.
A review. Curr Pharm Biotechnol. 2019;20(3):183-196. doi: 10.1128/JCM.02717-15
Volume 1 Issue 2 (2024) 95 doi: 10.36922/aih.2284

